September 22, 2021 - The National Research Council of Canada must determine whether the proposed Clinical Trial Material Facility, located at the NRC Royalmount site in Montréal, Québec is likely to cause significant adverse environmental effects.

To inform this determination, the National Research Council is inviting comments from the public respecting that determination.  All comments received will be considered public [and may be posted online].  For more information, individuals should consult the Privacy Notice on the Registry website. 

Written comments be submitted by October 13, 2021 to:

Document Reference Number: 2

Date modified: